Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer

Pierre Fumoleau, David Cameron

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Future options with capecitabine (Xeloda) in (neo)adjuvant treatment of breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences